Tumor growth rate is an early indicator of antitumor drug activity in phase I clinical trials.
Ferté C, Fernandez M, Hollebecque A, Koscielny S, Levy A, Massard C, Balheda R, Bot B, Gomez-Roca C, Dromain C, Ammari S, Soria JC.
Ferté C, et al. Among authors: dromain c.
Clin Cancer Res. 2014 Jan 1;20(1):246-52. doi: 10.1158/1078-0432.CCR-13-2098. Epub 2013 Nov 15.
Clin Cancer Res. 2014.
PMID: 24240109
Free PMC article.